Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

BARCELONA, Spain — Data on the controversial topic of testosterone replacement therapy in men with prostate cancer will be in the spotlight here at the European Association of Urology (EAU) 2019 ...

DEAR DR. ROACH: Approximately five years ago, I was diagnosed with an aggressive prostate cancer. My urologist referred me for radiation therapy, to be followed by Lupron every six months for two ...

Testosterone replacement therapy (TRT) is indicated in hypogonadal symptomatic men, where contraindications to treatment do not exist. The International Society for the Study of the Aging Male ...

BOSTON – A retrospective analysis by researchers at Beth Israel Deaconess Medical Center published in The New England Journal of Medicine found no causal relationship between testosterone replacement ...

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized ...

Dulaglutide Approved for Type 2 Diabetes Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth. A study from a group of researchers at the University of Illinois in Chicago ...

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...